PATI is Now FDA Cleared

EPILEPSY IS THE 4th LEADING NEUROLOGIC DISORDER IN THE WORLD

welcome to NeuroVice

No more spoons, towels, or pencils. No more pain. No more blood. No more suffering without a solution. FINALLY, MEET PATI, A SEIZURE SOLUTION FOR ORAL HEALTH.

PEOPLE WITH EPILEPSY IN U.S.
0 MILLION
ARE CHILDREN
0
65 million worldwide have epilepsy
0 MILLION
people will develop epilepsy in their lifetime
1/ 0

PATI - The pre-seizure rescue device

We have finally developed a solution

Meet PATI, The Protector Against Tongue Injury, developed by a patient for a patient. 

PATI is the first, symptom-management, oral device technology that safely and effectively protects against tongue biting and oral trauma during seizures. 

PATI’s patent-pending, disposable design protects against dislocation or dislodgment during the episode, allows for natural airflow, and protects against saliva from collecting in the mouth which can lead to choking. 

people live with seizures caused by strokes, traumatic brain injuries, brain tumors, multiple sclerosis and cerebral palsy
0 MILLION

don't put anything in the mouth

PATI finally provides seizure patients with a safe and effective, first solution of its kind.

IT'S EASY TO GET STARTED

The PATI comes in portable, tear away, single-use pouches. When you run out of PATIs refill your prescription.

Ashlyn Sanders, CEO & Founder

In 2014, Ashlyn was diagnosed with a rare neurologic condition called a Chiari Malformation, that led to emergent brain surgery. She also suffered from seizures. There is no cure for Chiari Malformations. Ashlyn started the company based on her desire to improve the patient experience for millions of others living with seizures.  

Ashlyn is a graduate of UNC-Chapel Hill (B.A. in Mathematics) and Duke University (M.A. in Bioethics and Science Policy). She is also a former 2014 Spring White House Intern during the Obama Administration in The Office of Science and Technology Policy and The Office of Public Engagement. She is passionate about health and health policy and is very active in her community. Ashlyn is currently a 4th-year medical student at Wake Forest University School of Medicine and plans to pursue pediatric neurology.